Future Trials: Decentralized, Direct to Patient and Clinical Research Virtual Conference

Biography: Tim McCarthy is VP & Head of Digital Medicine & Translational Imaging in Early Clinical Development at Pfizer. His team has two areas of focus: Digital Medicine, a group dedicated to the evaluation, qualification and operationalization of sensors and wearable technologies as novel endpoints in clinical trials and; Clinical & Translational Imaging, which works across the enterprise to provide imaging expertise (e.g. MRI, PET, CT, Ultrasound) and solutions to teams in both early (idea to proof of concept) and late-stage development. Tim has a background in Positron Emission Tomography, which he obtained during his time as a faculty member in Radiology at Washington University School of Medicine in St Louis. In 2001 Tim joined Pfizer to pursue his interests in applying translational imaging to drug development. Following the Pfizer acquisition, he has had roles of increasing responsibility and was most recently appointed to his current role in 2018. He is based in Cambridge, MA. Outside of Pfizer, Tim has been active in the imaging community; he was President of the Academy of Molecular Imaging (AMI) from 2008-11 and he is a founding director and past-president of the Society of Non-Invasive Imaging in Drug Development (SNIDD). Tim received his B.Sc. and Ph.D. in Organic Chemistry from the University of Liverpool, UK and his MBA from Washington University in St Louis.

Session Details: View In Agenda

Biography:

Session Details: View In Agenda

Biography: Revati Tatake currently serves as a Global Director of Databases and Analytics at GlobalData, where her primary responsibilities are to lead the development and continuous enhancement of integrated databases and analytical tools for providing competitive and business intelligence for pharmaceutical and biotechnology sectors Revati has more than 20 years’ experience, both in academic research and the healthcare industry, during which time she focused on basic and clinical research, drug discovery and competitive intelligence projects across many therapeutic areas.  After academic career at Tata Cancer Research Institute and the University of Connecticut Health Center, she began her healthcare industry career at Boehringer Ingelheim Pharmaceuticals, where she led drug discovery projects involving small molecules, gene therapy and cell therapy for cardiovascular diseases, Rheumatoid arthritis and Diabetes.  In addition to leading drug discovery projects, Revati co-chaired novel target identification group, scouted novel technologies for enhancing drug discovery efforts, established collaborations with experts in academic institutions to complement internal projects and evaluated in-licensing opportunities for their scientific and technical merit.  She is a co-inventor on several issued US patents and applications related to the projects on cell and gene therapies. Before joining GlobalData, Revati worked at Citeline, where she was involved in competitive intelligence and analytics of clinical trials and pharmaceutical products. Revati holds a PhD in Tumor Immunology from Tata Cancer Research Institute. She was a post-doctoral fellow at the University of Connecticut Health Center.

Session Details: View In Agenda

Biography:

Session Details: View In Agenda